Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/31806
Title: | The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh |
Authors: | Ahmed, S Dorin, F Satter, SM Sarker, AR Sultana, M Gastanaduy, PA Parashar, U Tate, JE Heffelfinger, JD Gurley, ES Khan, JAM |
Keywords: | economic burden;rotavirus gastroenteritis;diarrhea;costs-of-illness;catastrophic health expenditure;Bangladesh |
Issue Date: | 30-Oct-2021 |
Publisher: | Elsevier |
Citation: | Ahmed, S. et al. (2021) 'The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh', Vaccine, 39 (48), pp. 7082 - 7090. doi: 10.1016/j.vaccine.2021.10.003. |
Abstract: | Background: Rotavirus is a common cause of severe acute gastroenteritis among young children. Estimation of the economic burden would provide informed decision about investment on prevention strategies (e.g., vaccine and/or behavior change), which has been a potential policy discussion in Bangladesh for several years. Methods: We estimated the societal costs of children <5 years for hospitalization from rotavirus gastroenteritis (RVGE) and incidences of catastrophic health expenditure. A total of 360 children with stool specimens positive for rotavirus were included in this study from 6 tertiary hospitals (3 public and 3 private). We interviewed the caregiver of the patient and hospital staff to collect cost from patient and health facility perspectives. We estimated the economic cost considering 2015 as the reference year. Results: The total societal per-patient costs to treat RVGE in the public hospital were 126 USD (95% CI: 116–136) and total household costs were 161 USD (95% CI: 145–177) in private facilities. Direct costs constituted 38.1% of total household costs. The out-of-pocket payments for RVGE hospitalization was 23% of monthly income and 76% of households faced catastrophic healthcare expenditures due to this expense. The estimated total annual household treatment cost for the country was 10 million USD. Conclusions: A substantial economic burden of RVGE in Bangladesh was observed in this study. Any prevention of RVGE through cost-effective vaccination or/and behavioural change would contribute to substantial economic benefits to Bangladesh. |
Description: | Supplementary material is available online at: https://www.sciencedirect.com/science/article/pii/S0264410X21013104#s0090 . |
URI: | https://bura.brunel.ac.uk/handle/2438/31806 |
DOI: | https://doi.org/10.1016/j.vaccine.2021.10.003 |
ISSN: | 0264-410X |
Other Identifiers: | ORCiD: Sayem Ahmed https://orcid.org/0000-0001-9499-1500 |
Appears in Collections: | Dept of Health Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | Copyright © Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ (see: https://www.elsevier.com/about/policies/sharing). | 708.1 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License